The link between immunity and hypertension in the kidney and heart
Frontiers in Cardiovascular Medicine · 09.03.2023 · 10
DOI: 10.3389/fcvm.2023.1129384 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 09.03.2023. Verfasst von Lance N Benson und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, University of Arkansas for Medical Sciences, Little Rock, United States. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 204 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Hypertension is the primary cause of cardiovascular disease, which is a leading killer worldwide. Despite the prevalence of this non-communicable disease, still between 90% and 95% of cases are of unknown or multivariate cause (“essential hypertension”). Current therapeutic options focus primarily on lowering blood pressure through decreasing peripheral resistance or reducing fluid volume, but fewer than half of hypertensive patients can reach blood pressure control. Hence, identifying unknown mechanisms causing essential hypertension and designing new treatment accordingly are critically needed for improving public health. In recent years, the immune system has been increasingly implicated in contributing to a plethora of cardiovascular diseases. Many studies have demonstrated the critical role of the immune system in the pathogenesis of hypertension, particularly through pro-inflammatory mechanisms within the kidney and heart, which, eventually, drive a myriad of renal and cardiovascular diseases. However, the precise mechanisms and potential therapeutic targets remain largely unknown. Therefore, identifying which immune players are contributing to local inflammation and characterizing pro-inflammatory molecules and mechanisms involved will provide promising new therapeutic targets that could lower blood pressure and prevent progression from hypertension into renal or cardiac dysfunction.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacology and Toxicology, University of Arkansas for Medical Sciences, Little Rock, United States.
Förderung
- NHLBI NIH HHS
- NIGMS NIH HHS
Zitieren
APA
Benson, L. N., Guo, Y., Deck, K., Mora, C., Liu, Y., & Mu, S. (2023). The link between immunity and hypertension in the kidney and heart. Frontiers in Cardiovascular Medicine, 10. https://doi.org/10.3389/fcvm.2023.1129384
Vancouver
Benson LN, Guo Y, Deck K, Mora C, Liu Y, Mu S. The link between immunity and hypertension in the kidney and heart. Frontiers in Cardiovascular Medicine. 2023;10. doi:10.3389/fcvm.2023.1129384
BibTeX
@article{Benson2023,
author = {Benson, Lance N and Guo, Yunping and Deck, Katherine and Mora, Christoph and Liu, Yunmeng and Mu, Shengyu},
title = {The link between immunity and hypertension in the kidney and heart},
journal = {Frontiers in Cardiovascular Medicine},
year = {2023},
volume = {10},
doi = {10.3389/fcvm.2023.1129384}
}
EUVIMED